Stockhub

Swedish Orphan Biovitrum AB: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 August 2022

14 August 2022

26 July 2022

  • curprev 23:3123:31, 26 July 2022‎ Chris talk contribs‎ 1,172 bytes +1,172‎ Created page with "Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin associated periodic syndr..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Swedish_Orphan_Biovitrum_AB’